Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
DGTI 2023
Programm
Personen
Suche
DE
Alle Personen
Dr. Sixten Körper
Ulm/ DE
IKT Ulm
Sortiert nach Typ
Datum
Vorsitz
20.09.2023
11:30
–
13:00
Sektionssitzungen
Sektion Präparative und therapeutische Apherese
MOA 01+02
22.09.2023
08:30
–
10:00
Workshops
Operator Seminar
MOA 03
Vortrag
21.09.2023
16:42
–
16:44
2 Min.
0 Min.
ePoster
PS-4-7
Characteristics of red cell transfusion dependent outpatients: a single center experience
Hemotherapy
21.09.2023
16:46
–
16:50
3 Min.
1 Min.
ePoster
PS-5-7
Unstimulated autologous and allogenic mononuclear cell apheresis
Immunotherapy
21.09.2023
17:10
–
17:15
3 Min.
2 Min.
ePoster
PS-3-9
SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays
COVID-19
21.09.2023
17:15
–
17:20
3 Min.
2 Min.
ePoster
PS-3-10
A randomised open-label trial of early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 as model of early treatment in a pandemia with a new pathogen: Experience from collection of very high-titer plasma from superimmunized individuals
COVID-19
Weitere Beteiligungen
21.09.2023
16:42
–
16:44
2 Min.
0 Min.
ePoster
PS-4-7
Characteristics of red cell transfusion dependent outpatients: a single center experience
Hemotherapy
21.09.2023
16:45
–
16:50
3 Min.
2 Min.
ePoster
PS-3-4
Validation of a modified rapid antibody test to identify COVID-19 patients with low neutralizing antibody titers in an outpatient setting
COVID-19
21.09.2023
16:46
–
16:50
3 Min.
1 Min.
ePoster
PS-5-7
Unstimulated autologous and allogenic mononuclear cell apheresis
Immunotherapy
21.09.2023
17:10
–
17:15
3 Min.
2 Min.
ePoster
PS-3-9
SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays
COVID-19
21.09.2023
17:15
–
17:20
3 Min.
2 Min.
ePoster
PS-3-10
A randomised open-label trial of early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 as model of early treatment in a pandemia with a new pathogen: Experience from collection of very high-titer plasma from superimmunized individuals
COVID-19
21.09.2023
17:20
–
17:25
3 Min.
2 Min.
ePoster
PS-3-11
Effective neutralizing and cellular immunity against SARS-CoV-2 after mRNA booster vaccination is associated with the activation of B cells and pDCs
COVID-19
21.09.2023
17:26
–
17:30
3 Min.
1 Min.
ePoster
PS-5-21
Dynamics in Apheresis of human hematopoietic Progenitor Cells
Stem Cells
v1.23.1
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz